News
EMOL HEALTH PROVIDES MEANINGFUL RESULTS IN ONCOLOGY
Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer that affects younger individuals and African Americans disproportionately. EMOL Health took part with...
NCCA Partners with EMOL Health
EMOL Health is pleased to announce a new partnership between EMOL Health and the National Cancer Care Alliance (NCCA). NCCA is a growing network of independent oncology practices...
EMOL Partner Becomes Nations First CIN
One of EMOL Health’s partners, the Quality Cancer Care Alliance (QCCA) has announced its intention to become a Clinically Integrated Network (CIN). The board of QCCA voted...